Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
about
Epidemiology and Prevention of Hepatitis B Virus InfectionAsian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma.Significance of viral status on occurrence of hepatitis B-related hepatocellular carcinoma.Seropositivity of hepatitis B e antigen and hepatocellular carcinoma.Clinical evaluation of urinary transforming growth factor-beta1 and serum alpha-fetoprotein as tumour markers of hepatocellular carcinoma.Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study.Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control studyCoinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis.The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.An appraisal of the efficacy and cost effectiveness of antenatal screening for hepatitis B.A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.Interaction between hepatitis B and C viruses in hepatocellular carcinogenesis.The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma.Recognition criteria for occupational cancers in relation to hepatitis B virus and hepatitis C virus in Korea.A mathematical model to estimate global hepatitis B disease burden and vaccination impact.The expression of HtrA2 and its diagnostic value in patients with hepatocellular carcinoma.
P2860
Q24810152-2996D293-34C6-4307-B2F5-752A5E9B110DQ30479629-08F543FE-FEF0-43EB-B247-EE9BA224EF26Q33661054-3183B917-C227-4B34-99CD-8BACEA136920Q35794991-8CEAFEE6-57C4-4874-A334-DBD497BC24D1Q36421615-67597E16-EC4B-48A5-958C-3E68AC5EF5C6Q36422777-CE496375-4B38-42EE-B4EA-1BBC1E21EA53Q36431812-C8CA0F4D-B435-4DBE-AA13-2F4983A72F04Q36622692-2847C9C4-F941-4B40-A5A8-1F1F29D67F5FQ37709943-24835FBC-8613-46D2-921E-A7FBE6077ED6Q40534566-AE76534F-9132-49A6-80C3-7F9328BAABF8Q41642454-E62FB45F-64BC-4C81-B011-4FC0205B3733Q42986473-75A24C9A-6F0F-4606-BF68-6210FC138BCBQ42998247-EF953574-B2E8-407C-83F4-020E40A7F157Q45388422-09C29E2A-D092-4531-8306-4B32505646C1Q48501525-06B4C4F3-0DDC-48D4-BE24-D06FD12DE0EEQ51961246-E2381093-9CAD-4F73-A4D4-FBD2F36F654CQ55335738-7D5AA73E-B5CD-475D-A540-CF32D6FBFFE5
P2860
Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Additive effect modification o ...... t of hepatocellular carcinoma.
@ast
Additive effect modification o ...... t of hepatocellular carcinoma.
@en
type
label
Additive effect modification o ...... t of hepatocellular carcinoma.
@ast
Additive effect modification o ...... t of hepatocellular carcinoma.
@en
prefLabel
Additive effect modification o ...... t of hepatocellular carcinoma.
@ast
Additive effect modification o ...... t of hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Additive effect modification o ...... t of hepatocellular carcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.283
P407
P577
1996-06-01T00:00:00Z
P5875
P6179
1030061330